Introduction
Low sexual desire and arousal are the most common sexual complaints among women, and commonly cause sexual dissatisfaction and personal distress [1] . These conditions were classified in the DSM-IV Text Revision as Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Arousal Disorder (FSAD) [2] respectively, but have been merged in the DSM-5 as Female Sexual Interest/Arousal Disorder (FSIAD) [3] .
The pharmacotherapeutic options for HSDD/FSIAD are limited, with only one approved drug on the market in the US [4] . This drug, flibanserin, is taken daily to increase overall sexual desire. There are other therapies in late stages of clinical development [5] [6] [7] [8] that are not taken daily, but instead taken on-demand, i.e. when a woman with HSDD/FSIAD wants to want to have sex. These medications are not intended to increase sexual desire continuously, but only prior to and during sexual activity. Measuring the efficacy of such an on-demand drug necessitates a different approach.
Flibanserin's efficacy was assessed using the Female Sexual Function Index (FSFI). The FSFI assesses different dimensions of female sexual functioning over the preceding four weeks [9] . The efficacy of an on-demand drug for HSDD/FSIAD is best determined by assessing the quality of a sexual event during which the drug was taken. Assessing sexual functioning retrospectively over a longer period of time, for example over four weeks as does the FSFI, gives a more distal estimation of an on-demand drug's influence on sexual functioning than assessing sexual functioning over the actual events during which the drug was taken. However, in order to determine an on-demand drug's efficacy, an estimation of long-term effects is necessary. This can be operationalized by evaluating the change in number of satisfactory sexual events (SSE) from a baseline establishment period (BLE) to an active treatment period (ATP) during which the on-demand therapy was used. The primary endpoint in such trials is the difference between active treatment and placebo treatment arms in the change in number of SSEs from baseline to end of treatment, which is one of the U.S. Food and Drug Agency's preferred primary endpoints for the indication HSDD/FSIAD [10] . For this, a standardized and validated sexual event questionnaire is necessary.
The aim of this research was to develop and validate a standardized event log for assessing sexual satisfaction and sexual functioning of a single sexual event. This patient reported outcome, the Sexual Event Diary (SED), underwent three cycles of development, starting with a 58-item version, followed by a 16-item version, and finally, an 11-item version. This patient-reported outcome instrument was developed to gather primary and (key) secondary endpoint data in clinical trials assessing the efficacy of on-demand drugs in women with HSDD/FSIAD.
Materials and methods

Questionnaire development
The first version of the SED included 58 items, which were selected based on literature review, expert opinion, and information from over 250 clinical interviews that were conducted at our laboratory with women having sexual problems. The items that were included were selected to provide a comprehensive representation of sexual functioning and sexual satisfaction of a sexual event. Three focus groups, two with five premenopausal women and one with five postmenopausal women, with (predominantly) sexual problems, were performed to discuss what constituted sexual satisfaction and whether the 58-item SED adequately measured satisfaction as well as all other relevant aspects of sexual functioning.
The Dutch pilot version of the 58-item SED was tested in 156 women with (n=89) and without (n=67) sexual problems. These data were used for the initial validation and item reduction. Aside from completing the SED regarding their last sexual event, the subjects were asked to select those 15 SED items that were most relevant to them in capturing sexual satisfaction and sexual functioning during an event. Principal Components Analysis was performed to determine the factors underlying the SED. Correlations of the items with global sexual satisfaction and Cronbach's alpha coefficients were calculated in order to assess internal consistency (reliability).
The goal was to develop a comprehensive and compact questionnaire that could adequately assess the quality of a sexual event without burdening the subject. Based on the gathered qualitative and psychometric assessments, the 58-item SED was reduced to a 16-item version. All participants of the focus groups, debriefing interviews and observational study described above provided written informed consent.
The first versions of the SED were called the 'Satisfaction of an Event Questionnaire' (SSEQ), but it was later renamed to SED because this name covered the content of the questionnaire more adequately. In the present article, only the name SED is used (also to refer to prior versions) for sake of clarity.
Data
Clinical studies
Reliability, validity, and responsiveness of the 16-item US-version of the SED were assessed using data collected during two clinical studies in the United States. Study 1 (clinical trail identifier: NCT01432665) investigated the efficacy and safety of on-demand use of 4 doses of the combined administration of sublingual testosterone (0.25 mg, 0.5 mg) and sildenafil (25 mg, 50 mg), compared to placebo and monotherapies, in women with HSDD with low sensitivity for sexual cues. Study 2 (NCT01743235) investigated the efficacy and safety of on-demand use of 4 doses of the combined administration of sublingual testosterone (0.25 mg, 0.5 mg) and buspirone (5 mg, 10 mg), compared to placebo and monotherapies, in women with HSDD and dysfunctional over-activation of sexual inhibitory mechanisms [5] . Following subsequent qualitative and quantitative validation, the 16-item SED was modified into the 11-item SED (see Appendix).
Finally, the reliability, validity, and responsiveness of the 11-item SED was assessed using data collected in a third US study (NCT02101203) [5] , in which the efficacy and safety of on-demand use of sublingual testosterone (0.5 mg) combined with buspirone (10 mg) was compared to placebo, in women with HSDD and dysfunctional over-activation of sexual inhibitory mechanisms. A total of 5281 16-item SED's were filled out by 188 women who were in the Intention To Treat (ITT) population of study 1. A total of 4604 16-item SED's were filled out by 183 women who were in the ITT population of study 2. A total of 1074 11-item SED's were filled out by 50 women of study 3. The ITT population contained 52 women, but data from two women were excluded because one had only incomplete SEDs and one completed her SEDs too long after the sexual events occurred. All completed questionnaires were used for the statistical analyses.
All three studies consisted of a 4-week BLE, two 4-week placebo run-in periods (PRI), and two 4-week ATP. These studies investigated the effect of on-demand therapies' influence on discrete sexual events. Because frequency of sexual events varies per individual, the number of sexual events for each subject in each study and each 4-week period varied, and thus the number of collected SEDs for each subject.
The SED was filled out on a secure web-based system (Viedoc TM Me, Pharma Consulting Group, Uppsala, Sweden) that the participants could access at home via computer or from their portable device.
All participants of the three trials provided written informed consent.
Levels of assessment
Reliability and validity of the 16-and 11-item SED were assessed at event level and at subject level. Analyses were performed on event level to establish reliability and validity of the questionnaire in its ability to assess sexual function of a discrete sexual event, and on subject level to assess sexual function of an individual. Thus subject level can be used to establish reliability and validity of the primary endpoint change in number of SSEs from BLE to ATP. For event level analyses, SED's filled out by the same woman were treated as independent events.
For subject level analyses, validity and reliability of subject mean scores were assessed over 4week periods. The SED mean scores in the BLE and those in the ATP period were calculated separately. The PRI mean scores were not included in the analyses at subject level.
For assessing known groups validity, SED mean scores in satisfying sexual events were compared with those in unsatisfying sexual events as reported by SED item 4 only on event level. For evaluating responsiveness on subject level, SED mean change scores from baseline in those subjects reporting study medication-dependent improvement could be compared with those reporting no study medication-dependent improvement. Medication-dependent improvement was assessed by the Subjective Evaluation of Gain questionnaire (SEG). This questionnaire was also administered in the 3 studies, and item 1 asked if subjects had experienced improvement in their sexual functioning attributable to the study medication in the preceding 4 weeks.
Listwise deletion was used to handle missing data and this resulted in the deletion of 13 of the 5281 events for study 1, in the deletion of 1 of 4604 events in study 2, and in the deletion of 10 of the 1074 events in study 3. At subject level, this resulted in deletion of 23 of 376 observations in study 1, 48 of 366 observations in study 2 and 17 of 100 observations in study 3, mostly due to no events being reported in the BLE or ATP period.
Quantitative assessment
Factor analysis
Exploratory factor analysis (EFA) was used to assess underlying dimensions of the Likert scale items (items 5 through 15 for study 1 and 2 and items 5 through 10 for study 3) at event and at subject level. At event level, EFA was conducted on the polychoric correlation matrices of the Likert scale items, because these data are ordinal. At subject level, Pearson correlation matrices of the average Likert scale items were used. Factor analysis was estimated using the maximum likelihood (ML) method. The number of factors to be retained was determined by inspecting the eigenvalues and scree-plots. Furthermore, Parallel Analyses (PA) based on a minimum rank factor analysis [11] were conducted to find the number of factors under possible violations of the multivariate normality assumption.
Reliability
Internal consistency was assessed using Cronbach's alpha coefficient, that provides a lowerbound for reliability. Inter-item and item-rest correlations were assessed using Pearson correlation coefficients. Inter-item correlations were used to assess the relationship between individual items within the SED. Item-rest correlations were used to assess the relationship between individual items and the total item sum score of the remaining items. Two different sum scores were used: an unweighted sum score of all SED Likert scale items, referred to as the SED total score, and an unweighted SED sexual function sum score, consisting of all relevant SED Likert scale items based on the results of the factor analyses and/or theoretical arguments. For the calculation of the SED sum score(s) and all statistical analyses, the answer categories of 16-item SED items 11 ('afraid of pain'), 12 ('disgust'), and 13 ('distracting thoughts') and 11-item SED item 8 ('distracting thoughts') were reversed, so that the answer categories of all items had the same direction.
Validity
At event level, construct validity was assessed by comparing the means of the SED item scores that were included in the scale with the dichotomous items assessing satisfaction, gratification
and orgasm (answer options: "yes" and "no").
At subject level, construct validity was assessed using the Pearson correlation coefficients of the total score and domain scores of the Sexual Function Questionnaire [9] (SFQ; studies 1 and 2) and the Female Sexual Function Index [12] (FSFI; study 3) with the sum scores and related domain items of the SED. The SFQ is a 34-item self report questionnaire that assesses seven domains of sexual function over the preceding 4 weeks: desire, arousal-sensation, arousallubrication, enjoyment, orgasm, pain, and partner relationship. The FSFI is a 19-item self report questionnaire that assesses six domains of sexual function over the preceding 4 weeks: desire, arousal, lubrication, orgasm, satisfaction and pain.
Also at subject level, known groups validity was assessed by comparing the mean SED scores over the ATP period between responders and non-responders, using independent sample T-test statistics. Responders were defined as those subjects who indicated experiencing improvement in the last 4 of the 8 weeks treatment using the SEG. Responders were subjects who answered "yes" to the question asking if they had experienced benefit from the medication during the last 4 weeks, and non-responders were those who answered "no". The responder classification was independent of study medication used.
Responsiveness
Responsiveness is the ability of the instrument to detect change when there is a known change in the measurement of interest. Responsiveness was assessed by comparing the means of the change from BLE to ATP in SED scores between responders and non-responders, by calculating independent sample T-test statistics.
Responsiveness was also assessed by determining the effect size statistics of the ability of the SED to measure change in sexual functioning using Guyatt's responsiveness index [13, 14] .
Effect sizes of about 0.20 represent small effects, those of about 0.50 represent moderate effects, and those ≥ 0.80 represent large effects [13] .
A two-sided 5% significance level was adopted for all statistical tests.
Qualitative assessment
Two iterative sets of cognitive debriefing interviews were held with women with HSDD in the Cognitive debriefing of the 11-item SED was conducted using a similar "think-aloud" procedure and directed probes to delve further into the question-answering process. At the end of each patient interview, participants were asked whether the 11-item SED missed any important concept that participants deemed critical to measuring satisfaction with a sexual event and whether any items included in the 11-item SED seemed irrelevant to participants for inclusion in a sexual event diary. Finally, from the concepts contained in the 11-item SED, participants were asked to select the three concepts that were most important to them in determining satisfaction with sexual activity.
Results
Participant characteristics
Baseline characteristics and demographics of women with HSDD who were included in psychometric assessments and who participated in the debriefing interviews are shown in Table 1 . 
16-item SED (study 1 and 2)
Event level
Factor analysis
Inspection of the eigenvalues and scree-plots of the ML factor analyses and results of the PA revealed that one factor should be retained. The first factor had an eigenvalue of 5.48, explaining 49.8% of the variance for study 1 and an eigenvalue of 5.56, explaining 50.5% of the variance for study 2. Items 5 through 10 and,15 had moderate (>.50) to strong (>.80) loadings, with less strong contributions of items 12, 13 and 14 ( Table 2 ). The SED sexual function sum score was derived using items 5 through 10 and items 13 through 15. Item 11 and 12 were not included because overall they had the lowest factor loadings.
Reliability
Items 5 through 10 and 13 through 15 gave a high Cronbach's alpha for both studies (see Table   3 ). Most inter-item Pearson correlation coefficients were over 0.30, see Supplementary, Tables A and B. Only items 11 ('afraid pain'), 12 ('disgust') in both studies and 13 ('distracting thoughts') in study 1 had correlations below 0.30. Item-rest Pearson correlation coefficients between 16item SED items 4 ('satisfied'), 3 ('gratified') and 16 ('orgasms'), with answer options "yes"/ "no", and the sum scores were all larger than 0.30 in both studies 1 and 2. Here the item-rest correlation coefficients between items 4 ('satisfied') and 3 ('gratified') and the sum scores were somewhat larger compared to 16 ('orgasm') for both studies. The item-rest Pearson correlation coefficients between the 16-item SED Likert items 5 to 15 and the sum scores were mostly larger than 0.30, except for item 11 ('afraid of pain') for both studies. 
Validity
All items that were included in the 16-item SED of study 1 and 2 showed strong known groups validity, since the mean differences in SED item and sum scores between "yes" and "no" responders on SED items measuring 'gratified', 'satisfied', and 'orgasm' were highly significant (all but one were P<0.0001), all in the expected direction (Table 4 ). 
Subject level
Factor analysis
Inspection of the eigenvalues and scree-plots of the ML factor analyses and results of the PA revealed that one factor should be retained. The first factor had an eigenvalue of 5.41, explaining 49.1% of the variance for study 1 and an eigenvalue 5.28, explaining 48.0% of the variance for study 2. Items 5 to 9 and 15 had strong factor loadings, with less strong contributions of items 10, 13 and 14 ( Table 2 ). Sexual function sum score was derived using the same items as for the event level analyses.
Reliability
The items gave a high Cronbach's alpha for both studies (see Table 2 ). Most inter-item Pearson correlation coefficients were over 0.30 (see Supplementary, Tables C and D). Only items 11
('afraid pain'), 12 ('disgust') for both studies, and 13 ('distracting thoughts') for study 1 had correlations lower than 0.30. Item-rest Pearson correlation coefficients between 16-item SED items 4 ('satisfied'), 3 ('gratified') and 16 ('orgasms'), with answer options "yes"/ "no", and the sum scores were all larger than 0.30 in both studies 1 and 2. The item-rest Pearson correlation coefficients between the 16-item SED Likert items 5 to 15 and the sum scores were mostly larger than 0.30, except for item 11 ('afraid pain') for both studies.
Validity
Convergent validity was deemed adequate, with correlation coefficients between the SFQ domains with their related 16-item SED items ranging from 0.33 to 0.77 for study 1 and from 0.22 to 0.80 for study 2 during both periods (see Supplementary, Tables E and F Responders, as defined by the SEG, had significantly higher 16-item SED item scores in Table 5 . 
Known Groups Responsiveness -Mean (SD) Change in 16-item SED scores from Baseline establishment to Active Treatment Period in responders and non-responders as defined by the SEG
11-item SED (study 3)
Cognitive debriefing interviews and item reduction
Content validity of the SED was assessed by conducting two iterative sets of cognitive debriefing interviews. The 16-item SED was tested in round 1, and following adaptation, the 11-item SED was tested in round 2. Each round included eight women (Table 1) who met the in-and exclusion criteria. Six of the interview participants were classified as having low sensitivity to sexual cues and two as demonstrating dysfunctional over-activity of sexual inhibitory mechanisms. This subdivision is based on the dual control model of sexual response and is substantiated by cognitive [15, 16] , psychophysiological [6, 7, [15] [16] [17] , subjective [6, 7, 16] , neuroanatomical [18, 19] and pharmacological [6, 7, 15, 16, 18] evidence. This information was collected to ascertain if these groups differed in opinions/perceptions regarding what is important for satisfactory sex. No differences were observed. Based on the results of these interviews in round 1, revisions were made to the item set, including the removal of items addressing concepts less important to patients and the development of new items to capture concepts of greater importance to patients.
SED item wording of the two versions, including a brief description of the type of change made is summarized in Supplementary, Table H . In round 1, all patients found the items 4 ('satisfied') and 16 ('orgasm') and the majority of patients found the items 5 ('pleasure'), 6 ('letting go') and 13
('distracting thoughts') clear, easy to understand and answer, and relevant for a sexual event diary. Therefore, these items were retained. Items 4 ('satisfied'), 6 ('letting go'), and 13
('distracting thoughts') were not modified, and for the items 5 ('pleasure') and 16 ('orgasm') minor modifications to wording were made, e.g., refinements to US English. The majority of the patients indicated that the 'gratified' item was measuring the same as the 'satisfaction' item; half of the patients preferred the item assessing 'satisfaction', and several said the term 'gratification'
was not clear (38%). As a consequence, the 'gratified' item was deleted without replacement.
Item 9 ('sexually aroused') was deleted and replaced since participants not always interpreted the question as asking for mental arousal. The item 7 ('in the mood for sex') was deleted and replaced, since participants found this item was not fully measuring desire. Several patients indicated that overall physical arousal was also important to assess instead of only vaginal arousal, as a result the item 8 ('vaginal arousal') was deleted and replaced. Items 10 ('body image'), 11 ('afraid of pain'), 12 ('disgust') and 14 ('partner attractiveness') and 15 ('partner's actions') were deemed irrelevant to a sexual event diary by interview participants. These items were therefore deleted without replacement. The deletion of item 11 ('afraid of pain') and item 12
('disgust') was also justified by evaluating the quantitative assessment results. Both items had overall the lowest factor loadings. The 11-item SED was then tested in round 2, which resulted in strong content validity. Nearly all participants found each item included in the SED clear, easy to answer and important to capture in a sexual event diary, so no changes were made to the final SED. An exception was the deletion of the "How would you rate" stem of SED items 6-9, since this item formulation generally did not perform well. The wording was changed to a more direct form, e.g., "How physically aroused or excited did you become during the sexual activity?". The psychometric data gathered in studies 1 and 2 supported the item selection for the SED.
Event level
Factor analysis
Inspection of the eigenvalues and scree-plots of the ML factor analyses and results of the PA revealed that one factor should be retained. The factor had an eigenvalue of 4.89, explaining 81.4% of the variance. The one-factor structure showed high loadings for all SED items ( Table   2 ). Because of this finding, the SED total sum score and the SED sexual function sum score were equal and consisted of all Likert scale items.
Reliability
Cronbach's alpha coefficient was high ( Table 3 ). The Pearson correlation coefficients, which were calculated for assessing the SED inter-item and item-rest correlations, were all larger than 0.30 (P<0.0001, see Supplementary, Table I ).
Validity
All SED items showed strong construct validity. The mean differences in SED scores between "yes" and "no" responders on SED items measuring 'satisfied' and 'orgasm' were highly significant (P<0.0001) and the results were in the expected direction (Table 6 ). 
Subject level
Factor analysis
Inspection of the eigenvalues and scree-plots of the ML factor analyses and results of the PA revealed that one factor should be retained. The factor had an eigenvalue of 4.66, explaining 77.7% of the variance. The one-factor structure showed high loadings for all items ( Table 2) .
Also here, the SED total sum score was equal to the SED sexual function sum score and consisted of all Likert scale items.
Reliability
Cronbach's alpha coefficient was high ( Table L ) on all items during the ATP, except on items 8
('distracting thoughts'), 9 ('letting go') and 11 ('orgasm').
Responsiveness
For responders increase in SED item scores from BLE to ATP was significantly higher than for non-responders (P<0.05, see Table 7 ) with exception of items 8 ('distracting thoughts') and 11
('orgasm') showing strong known groups responsiveness.
The Guyatt's effect sizes ranged from 0.73-1.58 indicating a very good ability to detect changes in SED item scores, see Table 7 . An exception was item 8 ('distracting thoughts') which had a small effect size (0.14). 
Discussion
A standardized event log, the SED, was developed for assessment of sexual satisfaction and sexual functioning of a single sexual event. The questions in the SED are directed at a discrete sexual event instead of being directed at sexual functioning over a longer period of time, e.g., four weeks. Measuring discrete sexual events gives a more valid assessment of efficacy of on-demand investigational drugs on sexual functioning of women with HSDD/FSIAD compared to questionnaires that are directed at assessment of sexual function over longer periods of time, e.g., SFQ, FSFI. This is because the influence of on-demand medication is predominantly present during an event and the data from event logs are therefore more proximate estimations of an on-demand drug's efficacy than data from monthly questionnaires, giving the advantage of minimized recall bias and increased precision. The results of the present study show that the SED is a valid and reliable measure for assessing female sexual function during discrete sexual events.
Reliability, validity and responsiveness were confirmed for the majority of the 11item SED items, based on evidence from cognitive debriefing interviews and psychometrical assessments in patients with HSDD. These findings indicated that most items measured the same concept of interest, the construct we intended to measure and changes in sexual functioning when change was reported. Our clinical trials' primary endpoint measure 'change in the number of satisfying sexual events from baseline', proved to be an excellent measure. This measure was comprehensive and correlated strongly with, and has excellent discriminating ability in, all aspects of sexual functioning. Furthermore, the SED showed to have a clear one-factor structure, indicating that the resulting scale (sum score) measured the same concept, and this scale showed excellent reliability, validity and responsiveness.
Discrepancies were found in our results regarding 11-item SED items 8
('distracting thoughts'), 9 ('letting go '), and 11 ('orgasm'). These appeared to be less valid and/or responsive according to psychometric assessments, whereas debriefing interviews revealed excellent content validity of all items included in the SED, indicating that they are appropriate and comprehensive relative to its intended measurement concept, population, and use. For item 11 ('orgasm') a lower validity than the other SED items was expected, because sexual satisfaction in women is less dependent on reaching orgasm than in men [20] . Nevertheless, for a substantial number of women, orgasm is an important aspect of sexual functioning [20] , and should therefore be assessed in clinical trials that investigate the efficacy of drugs for HSDD/FSIAD. The main reason 8 ('distracting thoughts') and 9 ('letting go') were included in the 11-item SED was to capture information on inhibition for the subtype of women in which HSDD/FSIAD is caused by dysfunctional over-activity of sexual inhibitory mechanisms. These women's sexual excitation is hampered by overactivity of normal inhibitory processes in the brain [18] , which may be expressed behaviorally as excessive distraction or an inability to let oneself go during sexual activity.
A limitation of the present study is that the final focus groups/cognitive interviews were performed in predominantly postmenopausal women, and predominantly women with low sensitivity to sexual cues. It is not expected that additional research in premenopausal and high inhibitory subjects would necessitate additional items or adjustment of items to reach concept saturation. There is no literature that suggest that there is a difference between women of these subgroups (pre-vs. postmenopausal, and low sensitive vs. high inhibitory) with respect to which aspects of a sexual event are
important. This will need to be confirmed in future research.
The SED was developed and validated as a part of a drug development program for HSDD/FSIAD. Development of and modifications to the SED were based on the premise that the instrument had to be a valid and reliable tool for use in such a program. The data that were used for the here described validation were also gathered in this program. Despite of this focus, however, the SED may also show merit in the assessment of sexual functioning of discrete sexual events in other areas of research, e.g., recreational drug use and sexual risky behaviors.
In conclusion, the 11-item SED has proven to be an excellent tool for measuring sexual satisfaction and sexual functioning over a single sexual event, and is therefore suitable for use in clinical trials assessing the efficacy of on-demand drugs in women with HSDD/FSIAD.
